AGNELLI, LUCA
AGNELLI, LUCA
Dipartimento di Oncologia ed Emato-Oncologia
ESR1 gene amplification and MAP3K mutations are selected during adjuvant endocrine therapies in relapsing Hormone Receptor-positive, HER2-negative breast cancer (HR+ HER2- BC)
2023 L. Ferrando, A. Vingiani, A. Garuti, C. Vernieri, A. Belfiore, L. Agnelli, G. Dagrada, D. Ivanoiu, G. Bonizzi, E. Munzone, L. Lippolis, M. Dameri, F. Ravera, M. Colleoni, G. Viale, L. Magnani, A. Ballestrero, G. Zoppoli, G. Pruneri
MGMT inactivation as a new biomarker in patients with advanced biliary tract cancers
2022 M. Niger, F. Nichetti, A. Casadei-Gardini, F. Morano, C. Pircher, E. Tamborini, F. Perrone, M. Canale, D.B. Lipka, A. Vingiani, L. Agnelli, A. Dobberkau, J. Hüllein, F. Korell, C.E. Heilig, S. Pusceddu, F. Corti, M. Droz, P. Ulivi, M. Prisciandaro, M. Antista, M. Bini, L. Cattaneo, M. Milione, H. Glimm, B.C. Köhler, G. Pruneri, D. Hübschmann, S. Fröhling, V. Mazzaferro, F. Pietrantonio, M. Di Bartolomeo, F. de Braud
Targeted RNA-sequencing analysis for fusion transcripts detection in tumor diagnostics: assessment of bioinformatic tools reliability in FFPE samples
2022 I. Capone, F. Bozzi, G.P. Dagrada, P. Verderio, E. Conca, A. Busico, M.A. Testi, V. Monti, M. Duca, C. Proto, S. Damian, A. Piccolo, F. Perrone, E. Tamborini, A. Devecchi, P. Collini, D. Lorenzini, A. Vingiani, L. Agnelli, G. Pruneri
Management of BRCA Tumour Testing in an Integrated Molecular Tumour Board Multidisciplinary Model
2022 J. Azzollini, A. Vingiani, L. Agnelli, E. Tamborini, F. Perrone, E. Conca, I. Capone, A. Busico, B. Peissel, E. Rosina, M. Ducceschi, M. Mantiero, S. Lopez, F. Raspagliesi, M. Niger, M. Duca, S. Damian, C. Proto, F. de Braud, G. Pruneri, S. Manoukian
Human pluripotent stem cells identify molecular targets of trisomy 12 in chronic lymphocytic leukemia patients
2021 J.C. Reid, D. Golubeva, A.L. Boyd, C.G. Hollands, C. Henly, L. Orlando, A. Leber, J. Hebert, F. Morabito, G. Cutrona, L. Agnelli, M. Gentile, M. Ferrarini, A. Neri, B. Leber, M. Bhatia
Fifteen-year follow-up of relapsed indolent non-Hodgkin lymphoma patients vaccinated with tumor-loaded dendritic cells
2021 G. Fuca`, M. Ambrosini, L. Agnelli, S. Brich, F. Sgambelluri, R. Mortarini, S.M. Pupa, M. Magni, L. Devizzi, P. Matteucci, A. Cabras, R. Zappasodi, F. De Santis, A. Anichini, F. De Braud, A.M. Gianni, M. Di Nicola
Bioinformatics Pipeline to Analyze lncRNA Arrays
2021 K. Todoerti, D. Ronchetti, M. Manzoni, E. Taiana, A. Neri, L. Agnelli
Revealing the Impact of Structural Variants in Multiple Myeloma
2020 E.H. Rustad, V.D. Yellapantula, D. Glodzik, K.H. Maclachlan, B. Diamond, E.M. Boyle, C. Ashby, P. Blaney, G. Gundem, M. Hultcrantz, D. Leongamornlert, N. Angelopoulos, L. Agnelli, D. Auclair, Y. Zhang, A. Dogan, N. Bolli, E. Papaemmanuil, K.C. Anderson, P. Moreau, H. Avet-Loiseau, N.C. Munshi, J.J. Keats, P.J. Campbell, G.J. Morgan, O. Landgren, F. Maura
NEAT1 Long Isoform Is Highly Expressed in Chronic Lymphocytic Leukemia Irrespectively of Cytogenetic Groups or Clinical Outcomek
2020 D. Ronchetti, V. Favasuli, P. Monti, G. Cutrona, S. Fabris, I. Silvestris, L. Agnelli, M. Colombo, P. Menichini, S. Matis, M. Gentile, R. Nurtdinov, R. Guigó, L. Baldini, G. Fronza, M. Ferrarini, F. Morabito, A. Neri, E. Taiana
Long non-coding RNA NEAT1 targeting impairs the DNA repair machinery and triggers anti-tumor activity in multiple myeloma
2020 E. Taiana, V. Favasuli, D. Ronchetti, K. Todoerti, F. Pelizzoni, M. Manzoni, M. Barbieri, S. Fabris, I. Silvestris, M.E. Gallo Cantafio, N. Platonova, V. Zuccalà, L. Maltese, D. Soncini, S. Ruberti, M. Cea, R. Chiaramonte, N. Amodio, P. Tassone, L. Agnelli, A. Neri
Tracing CLL-biased stereotyped immunoglobulin gene rearrangements in normal B cell subsets using a high-throughput immunogenetic approach
2020 M. Colombo, D. Bagnara, D. Reverberi, S. Matis, M. Cardillo, R. Massara, L. Mastracci, J.L. Ravetti, L. Agnelli, A. Neri, M. Mazzocco, M. Squillario, A.N. Mazzarello, G. Cutrona, A. Agathangelidis, K. Stamatopoulos, M. Ferrarini, F. Fais
Expression Pattern and Biological Significance of the lncRNA ST3GAL6-AS1 in Multiple Myeloma
2020 D. Ronchetti, K. Todoerti, C. Vinci, V. Favasuli, L. Agnelli, M. Manzoni, F. Pelizzoni, R. Chiaramonte, N. Platonova, N. Giuliani, P. Tassone, N. Amodio, A. Neri, E. Taiana
Integration of Transcriptional and Mutational Data Simplifies the Stratification of Peripheral T-Cell Lymphoma
2019 F. Maura, L. Agnelli, D. Leongamornlert, N. Bolli, J. Chan, A. Dodero, C. Carniti, T.B. Heavican, A. Pellegrinelli, G. Pruneri, A. Butler, S.G. Bhosle, A. Chiappella, A. Di Rocco, P.L. Zinzani, F. Zaja, R. Piva, G. Inghirami, W. Wang, T. Palomero, J. Iqbal, A. Neri, P.J. Campbell, P. Corradini
Expanding the repertoire of miRNAs and miRNA-offset RNAs expressed in multiple myeloma by small RNA deep sequencing
2019 L. Agnelli, A. Bisognin, K. Todoerti, M. Manzoni, E. Taiana, S. Galletti, G. Cutrona, E. Gaffo, S. Bortoluzzi, A. Neri
Long non-coding RNA NEAT1 shows high expression unrelated to molecular features and clinical outcome in multiple myeloma
2019 E. Taiana, D. Ronchetti, V. Favasuli, K. Todoerti, M. Manzoni, N. Amodio, P. Tassone, L. Agnelli, A. Neri
The new small tyrosine-kinase inhibitor ARQ531 targets acute myeloid leukemia cells by disrupting multiple tumor-addicted programs
2019 D. Soncini, S. Orecchioni, S. Ruberti, P. Minetto, C. Martinuzzi, L. Agnelli, K. Todoerti, A. Cagnetta, M. Miglino, M. Clavio, P. Contini, R. Varaldo, M. Bergamaschi, F. Guolo, M. Passalacqua, A. Nencioni, F. Monacelli, M. Gobbi, A. Neri, G. Abbadessa, S. Eathiraj, B. Schwartz, F. Bertolini, R.M. Lemoli, M. Cea
A retained transcriptomic profile characterizes CD138+ cells in the short time progression from smoldering to active multiple myeloma
2019 P. Storti, L. Agnelli, B. dalla Palma, K. Todoerti, V. Marchica, F. Accardi, G. Sammarelli, F. Deluca, D. Toscani, F. Costa, E. Vicario, G. Todaro, E. Martella, A. Neri, N. Giuliani
Targeted resequencing of FECH locus reveals that a novel deep intronic pathogenic variant and eQTLs may cause erythropoietic protoporphyria (EPP) through a methylation-dependent mechanism
2019 M. Chiara, I. Primon, L. Tarantini, L. Agnelli, V. Brancaleoni, F. Granata, V. Bollati, E. Di Pierro
Long Non-Coding RNAs in Multiple Myeloma
2018 R. Nobili, D. Ronchetti, L. Agnelli, E. Taiana, C. Vinci, A. Neri
Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity
2018 N. Amodio, M.A. Stamato, G. Juli, E. Morelli, M. Fulciniti, M. Manzoni, E. Taiana, L. Agnelli, M.E.G. Cantafio, E. Romeo, L. Raimondi, D. Caracciolo, V. Zuccalà, M. Rossi, A. Neri, N.C. Munshi, P. Tagliaferri, P. Tassone